Characteristic | Patients (n = 188) Number (%) |
---|---|
Age, median years | 37 (IQR 32-43) |
Male sex | 66 (35.1) |
Treatment interruption (days) | |
[1-30] | 82 (43.6) |
>30 | 22 (11.7) |
Total | 104 (55.3) |
CD4 lymphocyte at enrolment (n = 160) | |
CD4 count, median cells/mm3 | 100 (IQR 54-173) |
CD4 lymphocyte at end point (n = 160) | |
CD4 count, median cells/mm3 | 293 (IQR 188-431) |
Viral load at end point ≥1000 copies/ml | 58 (30.9) |
Genotypic drug-resistance mutations | 46 (24.5) |
HIV subtypes/CRFs | |
CRF02 | 26 |
CRF06 | 6 |
G | 1 |
Unique recombinant formsa | 13 |